Pangaea Ventures
VC Fund
Vancouver, Canada
Pangaea Ventures is a VC fund in Vancouver focused on Manufacturing and Biotechnology. Pangaea Ventures invests in companies solving fundamental problems in the world with advanced materials and hard technology; Impact Investor
- Total investments:
- 76
- Last investment:
- Lead investor:
- 34%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Pangaea Ventures invests in
Stages Pangaea Ventures invests in
Countries Pangaea Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Manufacturing 19 (25%)
- Biotechnology 11 (14%)
- Electronics 6 (8%)
- Health Care 6 (8%)
- Energy 4 (5%)
Stage
- Series A 16 (21%)
- Series B 15 (20%)
- Series C 11 (14%)
- Funding Round 9 (12%)
- Seed 3 (4%)
Country
- United States 26 (34%)
- Canada 9 (12%)
- The Netherlands 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Chris Erickson
General Partner
|
General Partner | Total investments: 7 | Find email | |
Matthew Cohen
Associate
|
Associate | Total investments: 1 | Find email | |
Purnesh Seegopaul
General Partner
|
General Partner | Total investments: 5 | Find email | |
Tracy Hedberg
Director, Finance and Administration
|
Director, Finance and Administration | Total investments: 0 | Find email | |
Andrew Haughian
General Partner
|
General Partner | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Dioseve
|
Dioseve is providing novel possibilities for all life. | $6.2M / Series A / Jun 11, 2026 | |
Kanvas Biosciences
|
Kanvas Biosciences developed cutting-edge imaging technology for microbial detection, providing unmatched speed, breadth, and adaptability. Kanvas aims to transform microbial research and infectious disease diagnostics through innovative imaging technology of the next generation. | $48M / Series A / May 05, 2026 | |
pH7
|
pH7 is a cleantech firm that develops and implements methods for the sustainable extraction and refining of strategic metals, which are required for the transition to renewable energy. This pilot project will offer the industry a solution for the sustainable extraction of Platinum Group Metals from secondary and primary resources using green,biodegradable, and recyclable solvents rather than smelting methodologies. | $25.6M / Series B / Dec 04, 2025 | |
Membrion
|
Membrion™ is a 2016 spin-out from the laboratories of the University of Washington (UW). Commercialization funding from the UW, the Murdock Charitable Trust, Amazon, the National Science Foundation (Award #1648517) and a consortium of California utilities (Rocket Fund) has helped to bridge the translation gap to a commercial product. In total, 11different funding organizations have evaluated and financially supported Membrion's product development and commercialization plan. Most recently, that support has translated to private investment by angel investors as they scale their technology into commercial production. | $20M / Series B / Oct 07, 2025 | |
Hinalea Imaging
|
Hinalea Imaging is a technology company that unifies the power of digital imaging to reveal critical details about a product. | $4.7M / Seed / Apr 25, 2025 | |
ChEmpower
|
ChEmpower is an advanced materials company that develops chemically reactive, abrasive-free planarization pads to improve chip yields and sustainability in semiconductor manufacturing. | $18.7M / Series A / Apr 24, 2025 | |
Aspect Biosystems
|
Aspect Biosystems is a privately held biotechnology company combining the power of microfluidics and 3D bioprinting to fuel medical research and the development of bioprinted therapeutics. By adopting Aspect’s microfluidic 3D bioprinting platform and collaborating within Aspect’s network, researchers worldwide are accelerating the development andcommercialization of 3D bioprinted tissues. In addition, Aspect is advancing its internal regenerative medicine programs focused on metabolic diseases and musculoskeletal injuries and disorders and partnering with key industry players to bring bioprinted therapeutics to the clinic. | $115M / Series B / Jan 08, 2025 | |
Green Theme Technologies
|
Green Theme Technologies is a developer of environmentally-friendly, dry textile finishing technology. It is a textile innovation company with the mission to create products that out-perform existing technologies while eliminating water usage and pollution. The company was founded in 2012 and is based in Rio Rancho, New Mexico. | $6M / Series C / Nov 06, 2024 | |
|
Kanvas Biosciences
|
Kanvas Biosciences developed cutting-edge imaging technology for microbial detection, providing unmatched speed, breadth, and adaptability. Kanvas aims to transform microbial research and infectious disease diagnostics through innovative imaging technology of the next generation. | $12.5M / Series A / Jul 01, 2024 | |
Biodel AG
|
Discoverer, developer & Manufacturer of Proprietary Biological Solutions for Regenerative Agriculture for use by Commercial Growers, Horticulture, and Homeowners | Series A / Sep 13, 2023 | |
| See all 76 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Pangaea Ventures invest in?
Pangaea Ventures invests primarily in Manufacturing, Biotechnology and Electronics startups, most often at Series A and Series B stage. Most of the 76 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Pangaea Ventures?
Public channels for Pangaea Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Pangaea Ventures?
The team at Pangaea Ventures includes Chris Erickson (General Partner), Matthew Cohen (Associate) and Purnesh Seegopaul (General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
